Not to say much, I think we are very much interested in this project but then we are not opting for the crowdfunding route. We also want to know what you see your valuation will look like in 3 years. We were wondering if you have provisions to accept alternative financing. Wit...

Thanks Thomas! Yes, we are simultaneously raising from accredited investors on the same terms, and I'd be happy to discuss it further :)

Hi, Can you tell us approximatey how much the machines cost to rent, how many get manufactured per year, and whether they can simply be bought and used by patients at home, like a blood pressure machine? Many thanks, Martin

Hi Martin -- thank you for the question! We have been thoughtful about our device partnerships in order to make sure we have supply chain security and the ability to quickly scale-up! We have two primary device partners currently. Our model is to bundle the off-the-shelf third party devices into our SaaS subscription for the software, which scales up with the number of devices the provider needs (both both in-clinic and at-home). Though there is some variability based on the account type, we ...

Sounds like a great idea. I wish you the best. I do have two related questions. What type of IP do you have? What are you offering that another company couldn't easily replicate?

Great question! We've built out our defensibility in two key areas: (1) the user-interface and ease-of-use to help patients and non-specialists perform spirometry quickly and accurately, and (2) the clinical decision support software that help non-specialists more quickly and easily understand the results. User-Interface & Ease of Use: Through our partnerships with clinical researchers, we have learned how to provide real-time coaching in our app. Basically, while performing the test, our...

This sounds like a great idea. I do have a couple of questions: do you plan to seek out government partnerships in the future, at any level? Given your comparisons of pulmonary tests to blood pressure tests and the constant debate over what Medicare and Medicaid should cover, ...

Hi Rachel, thank you for the thoughtful question! First, it's worth clarifying that our business model currently relies on both public insurance (like Medicare and Medicaid) and private insurance (like United Healthcare, Blue Cross Blue Shield, etc). Regardless of the insurance type patients have, our platform helps doctors do tests that are covered by existing insurance billing codes. As an example, one of our customers, Sovah Health, has received 100% of the insurance payments they have sub...

Any Investor Perks. This Idea seems great. Everyone knows someone who has asthma or COPD.

Thanks Adan! That's exactly why we started the company: to help those we love more proactively manage their conditions in partnership with their doctor. Because our service does require working the with a medical professional, we aren't currently offering any perks other than a great deal supporting a great mission :)

VitalFlo Updates, Team, and Funding Progress | Wefunder, Home of the Community Round

Backed by Geekdom Fund, Elevate Capital, and Purpose Built

UPDATE (1/12/2022): >26K spirometry tests performed on platform – 2.6X growth year-over-year!

UPDATE (1/12/2022): >1.5X subscription growth quarter-over-quarter throughout 2022!

UPDATE (12/13/2022): Awarded ADDITIONAL $500K, 2-year expansion of NSF SBIR grant!

Launched with 90-hospital Health System group in May 2022

Raised $2M+ in Seed funding in 2021 from 3 VCs and several Angels

Change asthma and COPD treatment to proactive, preventative care

Won $1.2M+ (Update: $1.7M+) in grant funding from National Science Foundation (NSF) and others

VitalFlo

VitalFlo helps doctors measure, monitor, and predict their patients' lung health

$826,078

VitalFlo

Quick facts

Team profiles

Featured investor profiles

$826,078

Ask